[Korea sinmijin financial newspaper reporter] Nitto Nitto Pharmaceutical Holdings and each held a shareholders' meeting in the headquarters auditorium Nitto Pharmaceutical 24th.
In particular, all members have launched over the last year, the pharmaceutical company split has opened the first general meeting of shareholders.
In the first phase Nitto Pharmaceutical Shareholders' Meeting re-elected the CEO of pharmaceutical yunungseop all members were determined. Some changes to the Articles of Incorporation, including the financial statements, etc. Approval was passed according to the original bill.
Nitto Pharmaceutical yunungseop CEO claiming focus on profitable growth through intensive innovation was emphasized efforts to raise long-term growth engines.
In the period after the 74th general meeting of shareholders held all members Holdings were passed, including the financial statements approved some changes to the Articles of Incorporation cases according to the original bill.
Jeongyeonjin inside directors and gimgakyoung re Appointment of directors and audit fees and the ceiling with the approval of all outside directors gun was also approved.
Representing all members Holdings yijeongchi directors at the shareholders' meeting is "all members Holdings has focused on each business companies to help focus on their business," he said "will make every effort to hand increase the value of existing brands to identify promising investment opportunities." he said.
Financial Daily Economic News FNTIMES - unauthorized reproduction for commercial purposes in accordance with the Copyright Act, No copying, distribution,
Copyright ⓒ Korea's financial newspaper & FNTIMES.com
